Aura Biosciences Inc - AURA Future Profit

AURA (Aura Biosciences Inc) - company brandmark

Aura Biosciences, Inc. (AURA) complies with environmental chemical disposal regulations within its laboratories. The business is entirely non-cyclical and resilient to macroeconomic downturns. The trajectory of future profitability helps assess returns, while the level records fresh values. The firm's advantage lies in the creation of innovative conjugates that precisely destroy cancer cells while preserving healthy tissue.

AURA: aurabiosciences.com Future Profit 07/04/2022 - 11/19/2026

Aura Bio - analytical breakdowns and key metrics (AURA)

- price and consensus price forecast:
Fundamental company analysis:aurabiosciences.com, AURA
Core merchandise of Aura Biosciences Inc

Aura Biosciences, Inc. (AURA) development of unique VDC-conjugates for targeted oncology therapy makes the success of Phase 3 clinical trials and FDA decisions key drivers of capitalization. This projected financial result aggregates market expectations for future revenues, neutralizing reporting lags and allowing investors to identify asset overvaluation in a timely manner to avoid freezing capital in an overheated business.

Main competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Candel Therapeutics CADL|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit